See also this year's filing and all EDGAR filings for this company.
PDF Report 0001671584_2023_Aptevo_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001671584, Aptevo Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 27,450,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,462,000 |
| 3 | remainder_Assets | 5,303,000 |
| 4 | LiabilitiesCurrent | 8,706,000 |
| 5 | LiabilitiesNoncurrent | 7,535,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 13,873,000 |
| 9 | ResearchAndDevelopmentExpense | 17,882,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 3,114,000 |
| 12 | remainder_NetIncome | 36,668,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 34,215,000 |
| 1 | Liabilities | 16,241,000 |
| 2 | Expenses | 31,755,000 |
| 3 | Revenues | 3,114,000 |
| 4 | StockholdersEquity | 17,974,000 |
| 5 | NetIncome | 8,027,000 |
| 6 | ComprehensiveNetIncome | 8,027,000 |
| 7 | BaseVar | 60,996,500 |
| 8 | EconomicCapitalRatio | 1.54 |
Edgar->Model Mapping
Feature Distribution
Change over Time
